Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) Investor Alert: Lawsuit Alleges Securities Laws Violations
An investor, who purchased shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Salix Pharmaceuticals, Ltd. in connection with certain allegedly false and misleading statements made between November 8, 2013 and November 6, 2014.
View full press release